-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EdUEgt9Ki97H1LIU/0BhNbrZe3RGR+SYXjMH++LTCVd4FnUFpo8awRDRoNj7AM16 WmBt/kumVHchKLc5c08OpA== 0001209191-05-013645.txt : 20050303 0001209191-05-013645.hdr.sgml : 20050303 20050303172319 ACCESSION NUMBER: 0001209191-05-013645 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050301 FILED AS OF DATE: 20050303 DATE AS OF CHANGE: 20050303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCULLION TONY CENTRAL INDEX KEY: 0001283978 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50642 FILM NUMBER: 05658848 BUSINESS ADDRESS: STREET 1: 100 PHILIPS PARKWAY CITY: MONITVALE STATE: NJ ZIP: 07645 BUSINESS PHONE: 2018027245 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEMORY PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001062216 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 100 PHILIPS PARKWAY CITY: MONTVALE STATE: NJ ZIP: 07645 BUSINESS PHONE: 2018027100 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-03-01 0 0001062216 MEMORY PHARMACEUTICALS CORP MEMY 0001283978 SCULLION TONY C/O MEMORY PHARMACEUTICALS CORP. 100 PHILIPS PARKWAY MONTVALE NJ 07645 1 1 0 0 Chief Executive Officer Common Stock 2005-03-01 4 M 0 8750 0.75 A 107306 D Common Stock 2005-03-01 4 S 0 8750 5.0064 D 98556 D Common Stock 2005-03-02 4 M 0 5000 0.75 A 103556 D Employee Stock Option (Right to Buy) 0.75 2005-03-01 4 M 0 8750 0.00 D 2002-04-01 2012-04-01 Common Stock 8750 43984 D Employee Stock Option (Right to Buy) 0.75 2005-03-02 4 M 0 5000 0.00 D 2001-09-04 2011-09-04 Common Stock 5000 295242 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2004. Date shown is the date of grant of option. 6.25% of the shares subject to the option become exercisable following each three month period after the date of grant. Option vests in full on the fourth anniversary of the grant date. Only represents the derivative securities of this class. Joseph M. Donabauer, Attorney-in-fact 2005-03-03 -----END PRIVACY-ENHANCED MESSAGE-----